Deutsche Bank
NERV icon

Deutsche Bank’s Minerva Neurosciences NERV Stock Holding History

Deutsche Bank’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$99.5K Sell
29,698
-3,579
-11% -$15.3K ﹤0.01% 3362
2026
Q2 		$185K Buy
+33,277
New +$180K ﹤0.01% 3299
2026
Q1 		– Sell
-1,500
Closed -$6.03K – 3699
2025
Q4 		$6.03K Buy
+1,500
New +$5.57K ﹤0.01% 3560
2021
Q3 		– Sell
-14,315
Closed -$266K – 4581
2021
Q2 		$266K Buy
14,315
+2,035
+17% +$43.8K ﹤0.01% 3620
2021
Q1 		$287K Buy
12,280
+6,788
+124% +$170K ﹤0.01% 3437
2020
Q4 		$103K Sell
5,492
-2,779
-34% -$70K ﹤0.01% 3835
2020
Q3 		$211K Buy
8,271
+6,244
+308% +$169K ﹤0.01% 3186
2020
Q2 		$58K Sell
2,027
-18,068
-90% -$1.06M ﹤0.01% 3738
2020
Q1 		$967K Buy
20,095
+18,778
+1,426% +$1.13M ﹤0.01% 2106
2019
Q4 		$74K Buy
1,317
+296
+29% +$13.1K ﹤0.01% 3736
2019
Q3 		$62K Sell
1,021
-1,640
-62% -$92.9K ﹤0.01% 3815
2019
Q2 		$119K Sell
2,661
-1,801
-40% -$90.1K ﹤0.01% 4120
2019
Q1 		$278K Sell
4,462
-2,026
-31% -$122K ﹤0.01% 3805
2018
Q4 		$349K Sell
6,488
-2,901
-31% -$212K ﹤0.01% 3554
2018
Q3 		$942K Buy
9,389
+533
+6% +$40.1K ﹤0.01% 3373
2018
Q2 		$585K Buy
8,856
+3,734
+73% +$227K ﹤0.01% 3762
2018
Q1 		$255K Sell
5,122
-3,437
-40% -$165K ﹤0.01% 4069
2017
Q4 		$413K Sell
8,559
-815
-9% -$40.4K ﹤0.01% 3707
2017
Q3 		$568K Buy
9,374
+5,399
+136% +$310K ﹤0.01% 3360
2017
Q2 		$280K Buy
3,975
+1,011
+34% +$65.4K ﹤0.01% 3753
2017
Q1 		$191K Buy
2,964
+1,489
+101% +$116K ﹤0.01% 3618
2016
Q4 		$138K Buy
1,475
+1,077
+271% +$110K ﹤0.01% 3899
2016
Q3 		$44K Buy
398
+85
+27% +$8.25K ﹤0.01% 4260
2016
Q2 		$24K Sell
313
-956
-75% -$60.8K ﹤0.01% 4703
2016
Q1 		$62K Buy
+1,269
New +$54.2K ﹤0.01% 4243
2015
Q3 		– Sell
-25
Closed -$1K – 5287
2015
Q2 		$1K Buy
+25
New +$1.07K ﹤0.01% 5276

Other funds holding NERV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Deutsche Bank's NERV Position: Q3 2026 in Review

Deutsche Bank reduced its Minerva Neurosciences (NERV) stake by 11% in Q3 2026, selling an estimated $15.3K and leaving 29,698 shares worth $99.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

Deutsche Bank first reported a position in NERV in Q2 2015 and has held it in 26 quarters since. The position peaked at $967K in Q1 2020. 15 funds tracked by Wall St. Rank hold NERV as of Q3 2026.

  • Deutsche Bank held 29,698 shares of Minerva Neurosciences worth $99.5K as of Q3 2026.
  • Deutsche Bank sold 3,579 Minerva Neurosciences shares in Q3 2026, an estimated $15.3K.
  • Minerva Neurosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3362 holding.
  • Deutsche Bank first reported a position in Minerva Neurosciences in Q2 2015 and has held it in 26 quarters since.
  • Deutsche Bank's Minerva Neurosciences position peaked at $967K in Q1 2020.
  • 15 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.